DAXXIFY
LIVE

Serial Number

50124721

Owner

Revance Therapeutics, Inc.

Attorney

Jennifer Waitman

First Use Date

Sep 26, 2022

Filing Date

Sep 23, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DAXXIFY Trademark

Serial Number: 50124721

DAXXIFY is a trademark filed by Revance Therapeutics, Inc. on September 23, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Revance Therapeutics, Inc. (87 trademarks)

7555 Gateway Blvd.
Newark, CA 94560

Entity Type: 03

Trademark Details

Filing Date

September 23, 2026

Registration Date

Not Registered

First Use Anywhere

September 26, 2022

First Use in Commerce

September 26, 2022

Goods & Services

Pharmaceutical preparations for the treatment of neurological, neuromuscular, and musculoskeletal disorders including muscle dystonias, cervical dystonia, blepharospasm, upper limb spasticity, cerebral palsy, muscle spasms, muscle tremors, smooth muscle disorders, autonomic nerve disorders, musculoskeletal disorders, headaches, migraines, pain, hyperhidrosis, excessive sweating, wrinkles, facial wrinkles, dynamic facial wrinkles, facial lines, glabellar lines, frown lines, and sports injuries, namely, injuries to skin, muscle, ligaments, or bone; botulinum toxin preparations and peptide-formulated preparations for medical, therapeutic, and aesthetic use; peptide substrates and botulinum toxin for use in the treatment of neurological disorders, neuromuscular disorders, muscle dystonias, cervical dystonia, blepharospasm, upper limb spasticity, cerebral palsy, muscle spasms, muscle tremors, smooth muscle disorders, autonomic nerve disorders, musculoskeletal disorders, headaches, migraines, pain, hyperhidrosis, excessive sweating, wrinkles, facial wrinkles, dynamic facial wrinkles, facial lines, glabellar lines, frown lines, and sports injuries, namely, injuries to skin, muscle, ligaments, or bone; analgesic and muscle relaxant pharmaceutical preparations; pharmaceutical preparations for use in dermatology; medicated skin care preparations; medicated body creams, lotions, and gels; and medicated eye creams, lotions, and gels

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 23, 2026 MAFR
NEW APPLICATION ENTERED
Sep 23, 2026 NWAP